University of Queensland coronavirus trial vaccine produces zero side effects in humans, hamsters

Australian COVID-19 vaccine produces ZERO side effects in human trials and provides protection against the virus in animals while reducing symptoms University of Queensland and CSL have trialled COVID-19 vaccine on humans The researchers have also injected hamsters with the drug in the Netherlands  Project co-leader Associate Professor Keith Chappell hailed animal trial success By … Read more

Cambridge joins the coronavirus vaccine race

1. GlaxoSmithKline and Sanofi Pasteur: 60million doses  The Government revealed on July 29 it had signed a deal with pharmaceutical giants GlaxoSmithKline (GSK) and Sanofi Pasteur If the vaccine proves successful, the UK could begin to vaccinate priority groups, such as frontline health and social care workers and those at increased risk from coronavirus, as early … Read more

Coronavirus China: Potential vaccine to given to key workers

China has been giving potential coronavirus vaccine to key workers since July, health official says Zheng, who is leading China’s vaccine development, revealed the news Saturday The nation launched ’emergency use’ of a potential COVID-19 vaccine on July 22 The health official said they are planning to ‘scale up’ the programme in autumn Comes as … Read more

China has been giving potential coronavirus vaccine to key workers since July

China has been giving potential coronavirus vaccine to key workers since July, health official says Zheng, who is leading China’s vaccine development, revealed the news Saturday The nation launched ’emergency use’ of a potential COVID-19 vaccine on July 22 The health official said they are planning to ‘scale up’ the programme in autumn Comes as … Read more

Donald Trump ‘could fast-track Oxford University’s Covid-19 vaccine’

US President Donald Trump could fast-track the coronavirus vaccine being made by Britain’s Oxford University to get it into use before the country’s election. White House insiders say Mr Trump is considering pushing for approval for emergency use of the jab, which is one of the world’s most promising candidates. Early trials of Oxford’s jab … Read more

Second Covid vaccine is being released by Russia which ‘avoids side effects of the first one’

A second Russian Covid-19 vaccine is on the way which ‘avoids the side-effects of the first one’ launched in a blaze of publicity by Vladimir Putin this month. The new drug is from a former top-secret Soviet biological weapons research plant in Siberia, now a world-leading virology institute. Clinical trials of Russia’s second vaccine named … Read more

Covid vaccine may not be ready for another year, warns Chief Medical Officer Chris Whitty

Covid vaccine may not be ready for another year, warns Chief Medical Officer Chris Whitty as he says he’d be ‘surprised’ if we had one by Christmas Whitty said Saturday there’s ‘reasonable chance’ of vaccine before next Winter   He warned that going into winter this year, Covid-19 could cause ‘real problems’  Whitty advised the country … Read more

Russia launches a SECOND Covid vaccine developed at former biological weapons plant

Russia says a second Covid-19 vaccine is on its way which ‘avoids the side-effects of the first one’.  Earlier this month, Vladimir Putin rushed to launch the Sputnik5 vaccine in a blaze of publicity, but criticism soon followed after test subjects reported numerous side effects. Russia’s release of the drug was met with widespread scepticism as to … Read more

Coronavirus: Pfizer’s second vaccine has fewer side effects

Pfizer’s second experimental coronavirus vaccine left HALF as many people with side effects compared to its first in a promising sign for a safe shot Both vaccines use part of the coronavirus’s genetic code. but B1 codes for part of the protein the virus uses to infect cells and B2 codes for the entire protein … Read more

Johnson & Johnson plans to launch largest-ever coronavirus vaccine trial with up to 60,000 people

Johnson & Johnson is planning to start a late-stage clinical trial of its experimental coronavirus vaccine in up to 60,000 people worldwide in late September. If the company hits the enrollment aim, which was reported on a US government database, it would be the largest-ever study looking at a possible immunization for the virus. Rival … Read more